[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fKzxH1oOuNS-zIjgL96gQMRLqg7dlhxRGuA83uKNVZeI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":84,"rows":91},"Region Skane",[4],367,false,124,8,494639,18,303,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Breast Cancer",9,{"name":18,"count":19},"Osteoarthritis",7,{"name":21,"count":22},"Stroke",6,{"name":24,"count":22},"Suicide, Attempted",{"name":26,"count":22},"Depression",{"name":28,"count":29},"Septic Shock",5,{"name":31,"count":29},"Hypertension",{"name":33,"count":29},"Cancer",[35,40,45,50,55,60,65,70,75,80],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT04451837","Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology","2021-12-15","Semaglutide",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT03406338","Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease","2024-09-01","Collagenase Clostridium Histolyticum",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06230081","Comparison Between Blocks or Not in Joint Arthroplasty","2025-03-30","Ropivacain 5 mg\u002Fml + Clonidine",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT03839862","Faecal Analyses in Spondyloarthritis Therapy","2025-12-31","TNF-inhibition",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT07169747","Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa","2026-10-01","Psilocybin",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT05755672","On-treatment Biomarkers in Metastatic Colorectal Cancer for Life","2026-12","Chemotherapy",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT06578234","Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses","2026-12-31","Adenosine",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT05635409","A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease","2027-01","STEM-PD",{"nctId":76,"briefTitle":77,"date":78,"intervention":79},"NCT07398287","Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease","2027-02","L-menthol",{"nctId":81,"briefTitle":82,"date":83,"intervention":49},"NCT07350252","Combination of Nerve Blocks and Local Infiltration Analgesia in Knee Arthroplasty","2027-03-01",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,127,175,205,223,241,264,286,311,329,371,392,410,440,458,480,501,523,549,585,607,632,657,683,701,729,747,770,798,816,841,870,888,917,935,970,988,1021,1039,1057,1075,1093,1111,1139,1157,1181,1199,1226,1255,1280,1304,1322,1348,1375,1393,1418,1445,1472,1498,1516,1541,1567,1585,1611,1638,1664,1691,1719,1737,1761,1785,1810,1828,1855,1881,1907,1930,1956,1974,1999,2017,2044,2068,2086,2113,2135,2160],{"intervention":49,"totalTrials":93,"cells":94},2,{"EARLY_PHASE1":95,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":116},{"trials":96,"activeCount":97},[],0,{"trials":99,"activeCount":97},[],{"trials":101,"activeCount":97},[],{"trials":103,"activeCount":97},[],{"trials":105,"activeCount":115,"soonestReadout":83},[106],{"nctId":81,"briefTitle":82,"status":107,"phases":108,"primaryCompletion":83,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":114},"RECRUITING",[89],"2027-09-01","2026-03-05",200,[113],"Osteo Arthritis of the Knee",[49],1,{"trials":117,"activeCount":115,"soonestReadout":48},[118],{"nctId":46,"briefTitle":47,"status":119,"phases":120,"primaryCompletion":48,"completion":121,"start":122,"enrollment":123,"conditions":124,"interventions":126},"ACTIVE_NOT_RECRUITING",[90],"2026-04-26","2024-02-01",400,[125],"Osteoarthritis of the Knee or Hip",[49],{"intervention":128,"totalTrials":93,"cells":129},"Shingrix",{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":136,"PHASE4":138,"NA":173},{"trials":131,"activeCount":97},[],{"trials":133,"activeCount":97},[],{"trials":135,"activeCount":97},[],{"trials":137,"activeCount":97},[],{"trials":139,"activeCount":115,"soonestReadout":157},[140,152],{"nctId":141,"briefTitle":142,"status":143,"phases":144,"primaryCompletion":145,"completion":145,"start":146,"enrollment":147,"conditions":148,"interventions":151},"NCT03886038","Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER)","COMPLETED",[89],"2022-02-15","2019-03-15",142,[149,150],"Rheumatoid Arthritis","Healthy Controls",[128],{"nctId":153,"briefTitle":154,"status":155,"phases":156,"primaryCompletion":157,"completion":158,"start":159,"enrollment":160,"conditions":161,"interventions":171},"NCT06763783","Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases","ENROLLING_BY_INVITATION",[89],"2029-12-31","2034-06-30","2024-12-17",240,[162,163,164,165,166,167,168,169,170],"Systemic Vasculitis","Spondylarthropathies","Psoriatic Arthritis","Scleroderma","Polymyalgia Rheumatica (PMR)","Juvenile Chronic Arthritis","Polyarthritis","SLE","Giant Cell Arteritis (GCA)",[128,172],"vaccination with 2 doses of Shingrix vaccine",{"trials":174,"activeCount":97},[],{"intervention":176,"totalTrials":115,"cells":177},"Penicillin G_1200mg",{"EARLY_PHASE1":178,"PHASE1":180,"PHASE2":182,"PHASE3":184,"PHASE4":186,"NA":203},{"trials":179,"activeCount":97},[],{"trials":181,"activeCount":97},[],{"trials":183,"activeCount":97},[],{"trials":185,"activeCount":97},[],{"trials":187,"activeCount":115,"soonestReadout":192},[188],{"nctId":189,"briefTitle":190,"status":107,"phases":191,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":196,"interventions":201},"NCT06726395","Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia",[89],"2028-04","2028-07","2025-03-10",420,[197,198,199,200],"Staphylococcus Aureus Bacteraemia","Staphylococcal Bacteraemia","Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)","Staphylococcus (S.) Aureus Infection",[176,202],"cloxacillin",{"trials":204,"activeCount":97},[],{"intervention":202,"totalTrials":115,"cells":206},{"EARLY_PHASE1":207,"PHASE1":209,"PHASE2":211,"PHASE3":213,"PHASE4":215,"NA":221},{"trials":208,"activeCount":97},[],{"trials":210,"activeCount":97},[],{"trials":212,"activeCount":97},[],{"trials":214,"activeCount":97},[],{"trials":216,"activeCount":115,"soonestReadout":192},[217],{"nctId":189,"briefTitle":190,"status":107,"phases":218,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":219,"interventions":220},[89],[197,198,199,200],[176,202],{"trials":222,"activeCount":97},[],{"intervention":172,"totalTrials":115,"cells":224},{"EARLY_PHASE1":225,"PHASE1":227,"PHASE2":229,"PHASE3":231,"PHASE4":233,"NA":239},{"trials":226,"activeCount":97},[],{"trials":228,"activeCount":97},[],{"trials":230,"activeCount":97},[],{"trials":232,"activeCount":97},[],{"trials":234,"activeCount":115,"soonestReadout":157},[235],{"nctId":153,"briefTitle":154,"status":155,"phases":236,"primaryCompletion":157,"completion":158,"start":159,"enrollment":160,"conditions":237,"interventions":238},[89],[162,163,164,165,166,167,168,169,170],[128,172],{"trials":240,"activeCount":97},[],{"intervention":69,"totalTrials":115,"cells":242},{"EARLY_PHASE1":243,"PHASE1":245,"PHASE2":247,"PHASE3":249,"PHASE4":251,"NA":262},{"trials":244,"activeCount":97},[],{"trials":246,"activeCount":97},[],{"trials":248,"activeCount":97},[],{"trials":250,"activeCount":97},[],{"trials":252,"activeCount":115,"soonestReadout":68},[253],{"nctId":66,"briefTitle":67,"status":107,"phases":254,"primaryCompletion":68,"completion":68,"start":255,"enrollment":256,"conditions":257,"interventions":261},[89],"2024-10-23",180,[258,259,260],"Chronic Coronary Syndrome","Coronary Artery Disease","Ischemic Heart Disease",[69],{"trials":263,"activeCount":97},[],{"intervention":44,"totalTrials":115,"cells":265},{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":272,"PHASE4":274,"NA":284},{"trials":267,"activeCount":97},[],{"trials":269,"activeCount":97},[],{"trials":271,"activeCount":97},[],{"trials":273,"activeCount":97},[],{"trials":275,"activeCount":115,"soonestReadout":43},[276],{"nctId":41,"briefTitle":42,"status":119,"phases":277,"primaryCompletion":43,"completion":278,"start":279,"enrollment":280,"conditions":281,"interventions":283},[89],"2027-09","2018-03-20",60,[282],"Dupuytren Disease of Finger",[44],{"trials":285,"activeCount":97},[],{"intervention":287,"totalTrials":115,"cells":288},"Afatinib\u002FDacomitinib",{"EARLY_PHASE1":289,"PHASE1":291,"PHASE2":293,"PHASE3":295,"PHASE4":307,"NA":309},{"trials":290,"activeCount":97},[],{"trials":292,"activeCount":97},[],{"trials":294,"activeCount":97},[],{"trials":296,"activeCount":115,"soonestReadout":301},[297],{"nctId":298,"briefTitle":299,"status":107,"phases":300,"primaryCompletion":301,"completion":301,"start":302,"enrollment":111,"conditions":303,"interventions":305},"NCT06486142","EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study",[88],"2028-09","2022-09-21",[304],"Non-Small Cell Lung Cancer",[287,306],"Osimertinib",{"trials":308,"activeCount":97},[],{"trials":310,"activeCount":97},[],{"intervention":306,"totalTrials":115,"cells":312},{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":325,"NA":327},{"trials":314,"activeCount":97},[],{"trials":316,"activeCount":97},[],{"trials":318,"activeCount":97},[],{"trials":320,"activeCount":115,"soonestReadout":301},[321],{"nctId":298,"briefTitle":299,"status":107,"phases":322,"primaryCompletion":301,"completion":301,"start":302,"enrollment":111,"conditions":323,"interventions":324},[88],[304],[287,306],{"trials":326,"activeCount":97},[],{"trials":328,"activeCount":97},[],{"intervention":79,"totalTrials":330,"cells":331},3,{"EARLY_PHASE1":332,"PHASE1":334,"PHASE2":336,"PHASE3":365,"PHASE4":367,"NA":369},{"trials":333,"activeCount":97},[],{"trials":335,"activeCount":97},[],{"trials":337,"activeCount":93,"soonestReadout":78},[338,350,359],{"nctId":339,"briefTitle":340,"status":341,"phases":342,"primaryCompletion":343,"completion":344,"start":345,"enrollment":346,"conditions":347,"interventions":349},"NCT07500974","Efficacy of L-menthol on Breathlessness in Asthma","NOT_YET_RECRUITING",[87],"2027-04","2027-05","2026-05",20,[348],"Asthma",[79],{"nctId":351,"briefTitle":352,"status":143,"phases":353,"primaryCompletion":354,"completion":354,"start":355,"enrollment":346,"conditions":356,"interventions":358},"NCT05888597","Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease",[87],"2025-04-30","2023-05-24",[357],"Chronic Obstructive Pulmonary Disease (COPD)",[79],{"nctId":76,"briefTitle":77,"status":107,"phases":360,"primaryCompletion":78,"completion":344,"start":361,"enrollment":346,"conditions":362,"interventions":364},[87],"2026-04-13",[363],"Interstitial Lung Disease (ILD)",[79],{"trials":366,"activeCount":97},[],{"trials":368,"activeCount":97},[],{"trials":370,"activeCount":97},[],{"intervention":39,"totalTrials":115,"cells":372},{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":386,"PHASE4":388,"NA":390},{"trials":374,"activeCount":97},[],{"trials":376,"activeCount":97},[],{"trials":378,"activeCount":115,"soonestReadout":38},[379],{"nctId":36,"briefTitle":37,"status":119,"phases":380,"primaryCompletion":38,"completion":68,"start":381,"enrollment":111,"conditions":382,"interventions":384},[87],"2020-09-10",[383],"Type2 Diabetes",[39,385],"Dapagliflozin",{"trials":387,"activeCount":97},[],{"trials":389,"activeCount":97},[],{"trials":391,"activeCount":97},[],{"intervention":385,"totalTrials":115,"cells":393},{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":404,"PHASE4":406,"NA":408},{"trials":395,"activeCount":97},[],{"trials":397,"activeCount":97},[],{"trials":399,"activeCount":115,"soonestReadout":38},[400],{"nctId":36,"briefTitle":37,"status":119,"phases":401,"primaryCompletion":38,"completion":68,"start":381,"enrollment":111,"conditions":402,"interventions":403},[87],[383],[39,385],{"trials":405,"activeCount":97},[],{"trials":407,"activeCount":97},[],{"trials":409,"activeCount":97},[],{"intervention":411,"totalTrials":115,"cells":412},"Aliskiren",{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":434,"PHASE4":436,"NA":438},{"trials":414,"activeCount":97},[],{"trials":416,"activeCount":97},[],{"trials":418,"activeCount":115,"soonestReadout":423},[419],{"nctId":420,"briefTitle":421,"status":107,"phases":422,"primaryCompletion":423,"completion":423,"start":424,"enrollment":425,"conditions":426,"interventions":432},"NCT04183101","Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy",[87],"2029-12","2020-10-01",30,[427,428,429,430,431],"C3 Glomerulopathy","Membranoproliferative Glomerulonephritis","Complement Abnormality","Dense Deposit Disease","C3 Glomerulonephritis",[411,433],"Enalapril",{"trials":435,"activeCount":97},[],{"trials":437,"activeCount":97},[],{"trials":439,"activeCount":97},[],{"intervention":433,"totalTrials":115,"cells":441},{"EARLY_PHASE1":442,"PHASE1":444,"PHASE2":446,"PHASE3":452,"PHASE4":454,"NA":456},{"trials":443,"activeCount":97},[],{"trials":445,"activeCount":97},[],{"trials":447,"activeCount":115,"soonestReadout":423},[448],{"nctId":420,"briefTitle":421,"status":107,"phases":449,"primaryCompletion":423,"completion":423,"start":424,"enrollment":425,"conditions":450,"interventions":451},[87],[427,428,429,430,431],[411,433],{"trials":453,"activeCount":97},[],{"trials":455,"activeCount":97},[],{"trials":457,"activeCount":97},[],{"intervention":59,"totalTrials":115,"cells":459},{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":474,"PHASE4":476,"NA":478},{"trials":461,"activeCount":97},[],{"trials":463,"activeCount":97},[],{"trials":465,"activeCount":115,"soonestReadout":58},[466],{"nctId":56,"briefTitle":57,"status":107,"phases":467,"primaryCompletion":58,"completion":468,"start":469,"enrollment":470,"conditions":471,"interventions":473},[87],"2027-10-01","2026-04-20",40,[472],"Anorexia Nervosa",[59],{"trials":475,"activeCount":97},[],{"trials":477,"activeCount":97},[],{"trials":479,"activeCount":97},[],{"intervention":74,"totalTrials":115,"cells":481},{"EARLY_PHASE1":482,"PHASE1":484,"PHASE2":493,"PHASE3":495,"PHASE4":497,"NA":499},{"trials":483,"activeCount":97},[],{"trials":485,"activeCount":115,"soonestReadout":73},[486],{"nctId":71,"briefTitle":72,"status":119,"phases":487,"primaryCompletion":73,"completion":488,"start":489,"enrollment":9,"conditions":490,"interventions":492},[86],"2027-11","2022-11-30",[491],"Parkinson Disease",[74],{"trials":494,"activeCount":97},[],{"trials":496,"activeCount":97},[],{"trials":498,"activeCount":97},[],{"trials":500,"activeCount":97},[],{"intervention":54,"totalTrials":115,"cells":502},{"EARLY_PHASE1":503,"PHASE1":505,"PHASE2":507,"PHASE3":509,"PHASE4":511,"NA":513},{"trials":504,"activeCount":97},[],{"trials":506,"activeCount":97},[],{"trials":508,"activeCount":97},[],{"trials":510,"activeCount":97},[],{"trials":512,"activeCount":97},[],{"trials":514,"activeCount":115,"soonestReadout":53},[515],{"nctId":51,"briefTitle":52,"status":107,"phases":516,"primaryCompletion":53,"completion":68,"start":517,"enrollment":518,"conditions":519,"interventions":522},[],"2019-01-01",50,[520,521],"Spondyloarthropathies","Ankylosing Spondylitis",[54],{"intervention":64,"totalTrials":115,"cells":524},{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":533,"NA":535},{"trials":526,"activeCount":97},[],{"trials":528,"activeCount":97},[],{"trials":530,"activeCount":97},[],{"trials":532,"activeCount":97},[],{"trials":534,"activeCount":97},[],{"trials":536,"activeCount":115,"soonestReadout":63},[537],{"nctId":61,"briefTitle":62,"status":107,"phases":538,"primaryCompletion":63,"completion":539,"start":540,"enrollment":541,"conditions":542,"interventions":548},[],"2033-03","2023-03-01",100,[543,544,545,546,547],"Metastatic Colorectal Cancer","Chemotherapy Effect","Peritoneal Metastases","Liver Metastasis Colon Cancer","Lung Metastases",[64],{"intervention":550,"totalTrials":93,"cells":551},"Methylprednisolone 40 mg",{"EARLY_PHASE1":552,"PHASE1":554,"PHASE2":556,"PHASE3":558,"PHASE4":572,"NA":583},{"trials":553,"activeCount":97},[],{"trials":555,"activeCount":97},[],{"trials":557,"activeCount":97},[],{"trials":559,"activeCount":97},[560],{"nctId":561,"briefTitle":562,"status":143,"phases":563,"primaryCompletion":564,"completion":564,"start":565,"enrollment":566,"conditions":567,"interventions":569},"NCT00806871","Steroid Injection Treatment of Carpal Tunnel Syndrome",[87,88],"2012-04","2008-11",112,[568],"Carpal Tunnel Syndrome",[550,570,571],"Methylprednisolone 80 mg","Sodium chloride",{"trials":573,"activeCount":97},[574],{"nctId":575,"briefTitle":576,"status":143,"phases":577,"primaryCompletion":578,"completion":578,"start":579,"enrollment":580,"conditions":581,"interventions":582},"NCT02652390","Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome",[89],"2016-10","2016-02",111,[568],[570,550],{"trials":584,"activeCount":97},[],{"intervention":570,"totalTrials":93,"cells":586},{"EARLY_PHASE1":587,"PHASE1":589,"PHASE2":591,"PHASE3":593,"PHASE4":599,"NA":605},{"trials":588,"activeCount":97},[],{"trials":590,"activeCount":97},[],{"trials":592,"activeCount":97},[],{"trials":594,"activeCount":97},[595],{"nctId":561,"briefTitle":562,"status":143,"phases":596,"primaryCompletion":564,"completion":564,"start":565,"enrollment":566,"conditions":597,"interventions":598},[87,88],[568],[550,570,571],{"trials":600,"activeCount":97},[601],{"nctId":575,"briefTitle":576,"status":143,"phases":602,"primaryCompletion":578,"completion":578,"start":579,"enrollment":580,"conditions":603,"interventions":604},[89],[568],[570,550],{"trials":606,"activeCount":97},[],{"intervention":608,"totalTrials":115,"cells":609},"Ropivacaine",{"EARLY_PHASE1":610,"PHASE1":612,"PHASE2":614,"PHASE3":616,"PHASE4":618,"NA":630},{"trials":611,"activeCount":97},[],{"trials":613,"activeCount":97},[],{"trials":615,"activeCount":97},[],{"trials":617,"activeCount":97},[],{"trials":619,"activeCount":97},[620],{"nctId":621,"briefTitle":622,"status":143,"phases":623,"primaryCompletion":624,"completion":625,"start":626,"enrollment":111,"conditions":627,"interventions":629},"NCT01726686","Pain Treatment After TKA With LIA and Intra-articular Continuous Infusion Pump",[89],"2011-07","2014-04","2010-02",[628],"Postoperative Pain Management",[608],{"trials":631,"activeCount":97},[],{"intervention":633,"totalTrials":115,"cells":634},"Prevenar vaccination",{"EARLY_PHASE1":635,"PHASE1":637,"PHASE2":639,"PHASE3":641,"PHASE4":643,"NA":655},{"trials":636,"activeCount":97},[],{"trials":638,"activeCount":97},[],{"trials":640,"activeCount":97},[],{"trials":642,"activeCount":97},[],{"trials":644,"activeCount":97},[645],{"nctId":646,"briefTitle":647,"status":143,"phases":648,"primaryCompletion":649,"completion":649,"start":650,"enrollment":651,"conditions":652,"interventions":654},"NCT00828997","Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar®",[89],"2018-01","2008-08",505,[149,653],"Spondylarthropathy",[633],{"trials":656,"activeCount":97},[],{"intervention":658,"totalTrials":115,"cells":659},"Isotonic riboflavin",{"EARLY_PHASE1":660,"PHASE1":662,"PHASE2":664,"PHASE3":666,"PHASE4":668,"NA":681},{"trials":661,"activeCount":97},[],{"trials":663,"activeCount":97},[],{"trials":665,"activeCount":97},[],{"trials":667,"activeCount":97},[],{"trials":669,"activeCount":97},[670],{"nctId":671,"briefTitle":672,"status":143,"phases":673,"primaryCompletion":674,"completion":674,"start":675,"enrollment":676,"conditions":677,"interventions":679},"NCT04427956","Corneal Crosslinking Treatment Study",[89],"2024-11-19","2017-05-23",54,[678],"Progressive Keratoconus",[658,680],"Hypotonic riboflavin",{"trials":682,"activeCount":97},[],{"intervention":680,"totalTrials":115,"cells":684},{"EARLY_PHASE1":685,"PHASE1":687,"PHASE2":689,"PHASE3":691,"PHASE4":693,"NA":699},{"trials":686,"activeCount":97},[],{"trials":688,"activeCount":97},[],{"trials":690,"activeCount":97},[],{"trials":692,"activeCount":97},[],{"trials":694,"activeCount":97},[695],{"nctId":671,"briefTitle":672,"status":143,"phases":696,"primaryCompletion":674,"completion":674,"start":675,"enrollment":676,"conditions":697,"interventions":698},[89],[678],[658,680],{"trials":700,"activeCount":97},[],{"intervention":702,"totalTrials":115,"cells":703},"Levobupivacaine",{"EARLY_PHASE1":704,"PHASE1":706,"PHASE2":708,"PHASE3":710,"PHASE4":712,"NA":727},{"trials":705,"activeCount":97},[],{"trials":707,"activeCount":97},[],{"trials":709,"activeCount":97},[],{"trials":711,"activeCount":97},[],{"trials":713,"activeCount":97},[714],{"nctId":715,"briefTitle":716,"status":143,"phases":717,"primaryCompletion":718,"completion":719,"start":720,"enrollment":721,"conditions":722,"interventions":725},"NCT03607227","Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery",[89],"2021-04-06","2021-04-07","2018-09-01",24,[723,724],"Head and Neck Cancer","Pain, Musculoskeletal",[702,726],"Saline Solution",{"trials":728,"activeCount":97},[],{"intervention":726,"totalTrials":115,"cells":730},{"EARLY_PHASE1":731,"PHASE1":733,"PHASE2":735,"PHASE3":737,"PHASE4":739,"NA":745},{"trials":732,"activeCount":97},[],{"trials":734,"activeCount":97},[],{"trials":736,"activeCount":97},[],{"trials":738,"activeCount":97},[],{"trials":740,"activeCount":97},[741],{"nctId":715,"briefTitle":716,"status":143,"phases":742,"primaryCompletion":718,"completion":719,"start":720,"enrollment":721,"conditions":743,"interventions":744},[89],[723,724],[702,726],{"trials":746,"activeCount":97},[],{"intervention":748,"totalTrials":115,"cells":749},"Oxygen",{"EARLY_PHASE1":750,"PHASE1":752,"PHASE2":754,"PHASE3":756,"PHASE4":758,"NA":768},{"trials":751,"activeCount":97},[],{"trials":753,"activeCount":97},[],{"trials":755,"activeCount":97},[],{"trials":757,"activeCount":97},[],{"trials":759,"activeCount":97},[760],{"nctId":761,"briefTitle":762,"status":143,"phases":763,"primaryCompletion":579,"completion":579,"start":764,"enrollment":541,"conditions":765,"interventions":767},"NCT01423929","Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion",[89],"2012-01",[766],"ST Elevation Myocardial Infarction",[748],{"trials":769,"activeCount":97},[],{"intervention":771,"totalTrials":115,"cells":772},"5% Albumin infusion 30 min",{"EARLY_PHASE1":773,"PHASE1":775,"PHASE2":777,"PHASE3":779,"PHASE4":781,"NA":796},{"trials":774,"activeCount":97},[],{"trials":776,"activeCount":97},[],{"trials":778,"activeCount":97},[],{"trials":780,"activeCount":97},[],{"trials":782,"activeCount":97},[783],{"nctId":784,"briefTitle":785,"status":143,"phases":786,"primaryCompletion":578,"completion":787,"start":625,"enrollment":788,"conditions":789,"interventions":794},"NCT02728921","The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery",[89],"2016-11",70,[790,791,792,793],"Pancreatic Neoplasms","Urogenital Neoplasm","Systemic Inflammatory Response Syndrome","Hypovolemia",[771,795],"5% Albumin infusion 3 hours",{"trials":797,"activeCount":97},[],{"intervention":795,"totalTrials":115,"cells":799},{"EARLY_PHASE1":800,"PHASE1":802,"PHASE2":804,"PHASE3":806,"PHASE4":808,"NA":814},{"trials":801,"activeCount":97},[],{"trials":803,"activeCount":97},[],{"trials":805,"activeCount":97},[],{"trials":807,"activeCount":97},[],{"trials":809,"activeCount":97},[810],{"nctId":784,"briefTitle":785,"status":143,"phases":811,"primaryCompletion":578,"completion":787,"start":625,"enrollment":788,"conditions":812,"interventions":813},[89],[790,791,792,793],[771,795],{"trials":815,"activeCount":97},[],{"intervention":817,"totalTrials":115,"cells":818},"Pegylated interferon-alfa-2b and ribavirin",{"EARLY_PHASE1":819,"PHASE1":821,"PHASE2":823,"PHASE3":825,"PHASE4":827,"NA":839},{"trials":820,"activeCount":97},[],{"trials":822,"activeCount":97},[],{"trials":824,"activeCount":97},[],{"trials":826,"activeCount":97},[],{"trials":828,"activeCount":97},[829],{"nctId":830,"briefTitle":831,"status":143,"phases":832,"primaryCompletion":833,"completion":833,"start":834,"enrollment":835,"conditions":836,"interventions":838},"NCT01045278","Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy",[89],"2013-09","2008-04",277,[837],"Hepatitis C",[817],{"trials":840,"activeCount":97},[],{"intervention":842,"totalTrials":115,"cells":843},"Modified Buckberg cardioplegic solution",{"EARLY_PHASE1":844,"PHASE1":846,"PHASE2":848,"PHASE3":850,"PHASE4":852,"NA":868},{"trials":845,"activeCount":97},[],{"trials":847,"activeCount":97},[],{"trials":849,"activeCount":97},[],{"trials":851,"activeCount":97},[],{"trials":853,"activeCount":97},[854],{"nctId":855,"briefTitle":856,"status":143,"phases":857,"primaryCompletion":858,"completion":859,"start":860,"enrollment":470,"conditions":861,"interventions":866},"NCT07386990","Cardioplegic Protection of the Heart",[89],"2021-11-18","2025-04-29","2021-06-15",[862,863,864,865],"Coronary Artery Bypass Graft (CABG)","Cardioplegia","Cardiopulmonary Bypass","Perioperative Myocardial Injury",[842,867],"Modified St Thomas´ cardioplegic solution",{"trials":869,"activeCount":97},[],{"intervention":867,"totalTrials":115,"cells":871},{"EARLY_PHASE1":872,"PHASE1":874,"PHASE2":876,"PHASE3":878,"PHASE4":880,"NA":886},{"trials":873,"activeCount":97},[],{"trials":875,"activeCount":97},[],{"trials":877,"activeCount":97},[],{"trials":879,"activeCount":97},[],{"trials":881,"activeCount":97},[882],{"nctId":855,"briefTitle":856,"status":143,"phases":883,"primaryCompletion":858,"completion":859,"start":860,"enrollment":470,"conditions":884,"interventions":885},[89],[862,863,864,865],[842,867],{"trials":887,"activeCount":97},[],{"intervention":889,"totalTrials":115,"cells":890},"13-valent pneumococcal conjugate vaccine",{"EARLY_PHASE1":891,"PHASE1":893,"PHASE2":895,"PHASE3":897,"PHASE4":899,"NA":915},{"trials":892,"activeCount":97},[],{"trials":894,"activeCount":97},[],{"trials":896,"activeCount":97},[],{"trials":898,"activeCount":97},[],{"trials":900,"activeCount":97},[901],{"nctId":902,"briefTitle":903,"status":143,"phases":904,"primaryCompletion":905,"completion":906,"start":907,"enrollment":908,"conditions":909,"interventions":913},"NCT03762824","Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease",[89],"2018-09-03","2020-12-21","2016-06-14",300,[149,910,911,162,912],"Systemic Lupus","Sjögren Syndrome","Spondyloarthritis",[889,914],"23-valent pneumococcal polysaccharide vaccine",{"trials":916,"activeCount":97},[],{"intervention":914,"totalTrials":115,"cells":918},{"EARLY_PHASE1":919,"PHASE1":921,"PHASE2":923,"PHASE3":925,"PHASE4":927,"NA":933},{"trials":920,"activeCount":97},[],{"trials":922,"activeCount":97},[],{"trials":924,"activeCount":97},[],{"trials":926,"activeCount":97},[],{"trials":928,"activeCount":97},[929],{"nctId":902,"briefTitle":903,"status":143,"phases":930,"primaryCompletion":905,"completion":906,"start":907,"enrollment":908,"conditions":931,"interventions":932},[89],[149,910,911,162,912],[889,914],{"trials":934,"activeCount":97},[],{"intervention":936,"totalTrials":93,"cells":937},"Pramipexole",{"EARLY_PHASE1":938,"PHASE1":940,"PHASE2":942,"PHASE3":944,"PHASE4":966,"NA":968},{"trials":939,"activeCount":97},[],{"trials":941,"activeCount":97},[],{"trials":943,"activeCount":97},[],{"trials":945,"activeCount":97},[946,957],{"nctId":947,"briefTitle":948,"status":143,"phases":949,"primaryCompletion":950,"completion":950,"start":951,"enrollment":952,"conditions":953,"interventions":956},"NCT05355337","Pramipexole for Anhedonic Depression",[88],"2025-06-04","2023-02-08",85,[954,955,26],"Psychiatric Disorders Mood","Anhedonia",[936],{"nctId":958,"briefTitle":959,"status":143,"phases":960,"primaryCompletion":961,"completion":961,"start":962,"enrollment":963,"conditions":964,"interventions":965},"NCT05825235","Long-term Efficacy of Pramipexole in Anhedonic Depression",[88],"2025-12-05","2023-04-21",55,[955,26],[936],{"trials":967,"activeCount":97},[],{"trials":969,"activeCount":97},[],{"intervention":571,"totalTrials":115,"cells":971},{"EARLY_PHASE1":972,"PHASE1":974,"PHASE2":976,"PHASE3":978,"PHASE4":984,"NA":986},{"trials":973,"activeCount":97},[],{"trials":975,"activeCount":97},[],{"trials":977,"activeCount":97},[],{"trials":979,"activeCount":97},[980],{"nctId":561,"briefTitle":562,"status":143,"phases":981,"primaryCompletion":564,"completion":564,"start":565,"enrollment":566,"conditions":982,"interventions":983},[87,88],[568],[550,570,571],{"trials":985,"activeCount":97},[],{"trials":987,"activeCount":97},[],{"intervention":989,"totalTrials":115,"cells":990},"polyethylene glycol",{"EARLY_PHASE1":991,"PHASE1":993,"PHASE2":995,"PHASE3":997,"PHASE4":1017,"NA":1019},{"trials":992,"activeCount":97},[],{"trials":994,"activeCount":97},[],{"trials":996,"activeCount":97},[],{"trials":998,"activeCount":97},[999],{"nctId":1000,"briefTitle":1001,"status":143,"phases":1002,"primaryCompletion":1003,"completion":1003,"start":1004,"enrollment":1005,"conditions":1006,"interventions":1011},"NCT05726097","Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure",[88],"2023-10-31","2023-02-01",147,[1007,1008,1009,1010],"Colon Cancer","Inflammatory Bowel Diseases","Gastrointestinal Bleed","Colon Polyp",[989,1012,1013,1014,1015,1016],"sodium phosphate","polyethylene glycol + ascorbic acid","gastrografin","magnesiumoxid + sodium picosulfate","prucalopride",{"trials":1018,"activeCount":97},[],{"trials":1020,"activeCount":97},[],{"intervention":1012,"totalTrials":115,"cells":1022},{"EARLY_PHASE1":1023,"PHASE1":1025,"PHASE2":1027,"PHASE3":1029,"PHASE4":1035,"NA":1037},{"trials":1024,"activeCount":97},[],{"trials":1026,"activeCount":97},[],{"trials":1028,"activeCount":97},[],{"trials":1030,"activeCount":97},[1031],{"nctId":1000,"briefTitle":1001,"status":143,"phases":1032,"primaryCompletion":1003,"completion":1003,"start":1004,"enrollment":1005,"conditions":1033,"interventions":1034},[88],[1007,1008,1009,1010],[989,1012,1013,1014,1015,1016],{"trials":1036,"activeCount":97},[],{"trials":1038,"activeCount":97},[],{"intervention":1013,"totalTrials":115,"cells":1040},{"EARLY_PHASE1":1041,"PHASE1":1043,"PHASE2":1045,"PHASE3":1047,"PHASE4":1053,"NA":1055},{"trials":1042,"activeCount":97},[],{"trials":1044,"activeCount":97},[],{"trials":1046,"activeCount":97},[],{"trials":1048,"activeCount":97},[1049],{"nctId":1000,"briefTitle":1001,"status":143,"phases":1050,"primaryCompletion":1003,"completion":1003,"start":1004,"enrollment":1005,"conditions":1051,"interventions":1052},[88],[1007,1008,1009,1010],[989,1012,1013,1014,1015,1016],{"trials":1054,"activeCount":97},[],{"trials":1056,"activeCount":97},[],{"intervention":1014,"totalTrials":115,"cells":1058},{"EARLY_PHASE1":1059,"PHASE1":1061,"PHASE2":1063,"PHASE3":1065,"PHASE4":1071,"NA":1073},{"trials":1060,"activeCount":97},[],{"trials":1062,"activeCount":97},[],{"trials":1064,"activeCount":97},[],{"trials":1066,"activeCount":97},[1067],{"nctId":1000,"briefTitle":1001,"status":143,"phases":1068,"primaryCompletion":1003,"completion":1003,"start":1004,"enrollment":1005,"conditions":1069,"interventions":1070},[88],[1007,1008,1009,1010],[989,1012,1013,1014,1015,1016],{"trials":1072,"activeCount":97},[],{"trials":1074,"activeCount":97},[],{"intervention":1015,"totalTrials":115,"cells":1076},{"EARLY_PHASE1":1077,"PHASE1":1079,"PHASE2":1081,"PHASE3":1083,"PHASE4":1089,"NA":1091},{"trials":1078,"activeCount":97},[],{"trials":1080,"activeCount":97},[],{"trials":1082,"activeCount":97},[],{"trials":1084,"activeCount":97},[1085],{"nctId":1000,"briefTitle":1001,"status":143,"phases":1086,"primaryCompletion":1003,"completion":1003,"start":1004,"enrollment":1005,"conditions":1087,"interventions":1088},[88],[1007,1008,1009,1010],[989,1012,1013,1014,1015,1016],{"trials":1090,"activeCount":97},[],{"trials":1092,"activeCount":97},[],{"intervention":1016,"totalTrials":115,"cells":1094},{"EARLY_PHASE1":1095,"PHASE1":1097,"PHASE2":1099,"PHASE3":1101,"PHASE4":1107,"NA":1109},{"trials":1096,"activeCount":97},[],{"trials":1098,"activeCount":97},[],{"trials":1100,"activeCount":97},[],{"trials":1102,"activeCount":97},[1103],{"nctId":1000,"briefTitle":1001,"status":143,"phases":1104,"primaryCompletion":1003,"completion":1003,"start":1004,"enrollment":1005,"conditions":1105,"interventions":1106},[88],[1007,1008,1009,1010],[989,1012,1013,1014,1015,1016],{"trials":1108,"activeCount":97},[],{"trials":1110,"activeCount":97},[],{"intervention":1112,"totalTrials":115,"cells":1113},"Ticagrelor",{"EARLY_PHASE1":1114,"PHASE1":1116,"PHASE2":1118,"PHASE3":1120,"PHASE4":1135,"NA":1137},{"trials":1115,"activeCount":97},[],{"trials":1117,"activeCount":97},[],{"trials":1119,"activeCount":97},[],{"trials":1121,"activeCount":97},[1122],{"nctId":1123,"briefTitle":1124,"status":1125,"phases":1126,"primaryCompletion":1127,"completion":1128,"start":1129,"enrollment":97,"conditions":1130,"interventions":1133},"NCT04069234","Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.","WITHDRAWN",[88],"2021-10-15","2022-03-31","2019-09-15",[1131,1132],"Diabetes Mellitus","Microvascular Coronary Artery Disease",[1112,1134],"Clopidogrel",{"trials":1136,"activeCount":97},[],{"trials":1138,"activeCount":97},[],{"intervention":1134,"totalTrials":115,"cells":1140},{"EARLY_PHASE1":1141,"PHASE1":1143,"PHASE2":1145,"PHASE3":1147,"PHASE4":1153,"NA":1155},{"trials":1142,"activeCount":97},[],{"trials":1144,"activeCount":97},[],{"trials":1146,"activeCount":97},[],{"trials":1148,"activeCount":97},[1149],{"nctId":1123,"briefTitle":1124,"status":1125,"phases":1150,"primaryCompletion":1127,"completion":1128,"start":1129,"enrollment":97,"conditions":1151,"interventions":1152},[88],[1131,1132],[1112,1134],{"trials":1154,"activeCount":97},[],{"trials":1156,"activeCount":97},[],{"intervention":1158,"totalTrials":115,"cells":1159},"sugar pill",{"EARLY_PHASE1":1160,"PHASE1":1162,"PHASE2":1164,"PHASE3":1175,"PHASE4":1177,"NA":1179},{"trials":1161,"activeCount":97},[],{"trials":1163,"activeCount":97},[],{"trials":1165,"activeCount":97},[1166],{"nctId":1167,"briefTitle":1168,"status":1125,"phases":1169,"primaryCompletion":1170,"completion":1170,"start":1170,"enrollment":97,"conditions":1171,"interventions":1173},"NCT01413854","Diclofenac add-on to Treatment as Usual for Suicidal Patients",[86,87],"2011-08",[1172],"Depression Suicidal",[1158,1174],"Diclofenac",{"trials":1176,"activeCount":97},[],{"trials":1178,"activeCount":97},[],{"trials":1180,"activeCount":97},[],{"intervention":1174,"totalTrials":115,"cells":1182},{"EARLY_PHASE1":1183,"PHASE1":1185,"PHASE2":1187,"PHASE3":1193,"PHASE4":1195,"NA":1197},{"trials":1184,"activeCount":97},[],{"trials":1186,"activeCount":97},[],{"trials":1188,"activeCount":97},[1189],{"nctId":1167,"briefTitle":1168,"status":1125,"phases":1190,"primaryCompletion":1170,"completion":1170,"start":1170,"enrollment":97,"conditions":1191,"interventions":1192},[86,87],[1172],[1158,1174],{"trials":1194,"activeCount":97},[],{"trials":1196,"activeCount":97},[],{"trials":1198,"activeCount":97},[],{"intervention":1200,"totalTrials":115,"cells":1201},"Pramipexole Pill",{"EARLY_PHASE1":1202,"PHASE1":1204,"PHASE2":1206,"PHASE3":1220,"PHASE4":1222,"NA":1224},{"trials":1203,"activeCount":97},[],{"trials":1205,"activeCount":97},[],{"trials":1207,"activeCount":97},[1208],{"nctId":1209,"briefTitle":1210,"status":143,"phases":1211,"primaryCompletion":1212,"completion":1212,"start":1213,"enrollment":1214,"conditions":1215,"interventions":1219},"NCT04121091","Pramipexole to Target \"Anhedonic Depression\"",[87],"2021-03-18","2019-10-04",13,[1216,1217,1218,955],"Depression, Bipolar","Depression, Unipolar","Dysthymia",[1200],{"trials":1221,"activeCount":97},[],{"trials":1223,"activeCount":97},[],{"trials":1225,"activeCount":97},[],{"intervention":1227,"totalTrials":115,"cells":1228},"Trametinib",{"EARLY_PHASE1":1229,"PHASE1":1231,"PHASE2":1233,"PHASE3":1249,"PHASE4":1251,"NA":1253},{"trials":1230,"activeCount":97},[],{"trials":1232,"activeCount":97},[],{"trials":1234,"activeCount":97},[1235],{"nctId":1236,"briefTitle":1237,"status":1238,"phases":1239,"primaryCompletion":1240,"completion":1241,"start":1242,"enrollment":1243,"conditions":1244,"interventions":1248},"NCT03741101","Treatment of NF1-related Plexiform Neurofibroma With Trametinib","UNKNOWN",[87],"2024-07-15","2024-12-15","2019-06-10",15,[1245,1246,1247],"Neurofibromatosis 1","Child","Neurofibroma, Plexiform",[1227],{"trials":1250,"activeCount":97},[],{"trials":1252,"activeCount":97},[],{"trials":1254,"activeCount":97},[],{"intervention":1256,"totalTrials":115,"cells":1257},"Ioflupane I123",{"EARLY_PHASE1":1258,"PHASE1":1260,"PHASE2":1262,"PHASE3":1274,"PHASE4":1276,"NA":1278},{"trials":1259,"activeCount":97},[],{"trials":1261,"activeCount":97},[],{"trials":1263,"activeCount":97},[1264],{"nctId":1265,"briefTitle":1266,"status":1267,"phases":1268,"primaryCompletion":1269,"completion":1269,"start":1270,"enrollment":29,"conditions":1271,"interventions":1273},"NCT03185182","Diagnostic Imaging for Clear Cell Renal Cell Carcinoma","TERMINATED",[87],"2018-09-12","2017-07-14",[1272],"Clear Cell Renal Cell Carcinoma",[1256],{"trials":1275,"activeCount":97},[],{"trials":1277,"activeCount":97},[],{"trials":1279,"activeCount":97},[],{"intervention":1281,"totalTrials":115,"cells":1282},"Nasal oxygen",{"EARLY_PHASE1":1283,"PHASE1":1285,"PHASE2":1287,"PHASE3":1298,"PHASE4":1300,"NA":1302},{"trials":1284,"activeCount":97},[],{"trials":1286,"activeCount":97},[],{"trials":1288,"activeCount":97},[1289],{"nctId":1290,"briefTitle":1291,"status":143,"phases":1292,"primaryCompletion":1293,"completion":1293,"start":624,"enrollment":908,"conditions":1294,"interventions":1296},"NCT01413841","Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief",[87],"2012-06",[1295],"Angina",[1281,1297],"Regular nasal air",{"trials":1299,"activeCount":97},[],{"trials":1301,"activeCount":97},[],{"trials":1303,"activeCount":97},[],{"intervention":1297,"totalTrials":115,"cells":1305},{"EARLY_PHASE1":1306,"PHASE1":1308,"PHASE2":1310,"PHASE3":1316,"PHASE4":1318,"NA":1320},{"trials":1307,"activeCount":97},[],{"trials":1309,"activeCount":97},[],{"trials":1311,"activeCount":97},[1312],{"nctId":1290,"briefTitle":1291,"status":143,"phases":1313,"primaryCompletion":1293,"completion":1293,"start":624,"enrollment":908,"conditions":1314,"interventions":1315},[87],[1295],[1281,1297],{"trials":1317,"activeCount":97},[],{"trials":1319,"activeCount":97},[],{"trials":1321,"activeCount":97},[],{"intervention":1323,"totalTrials":115,"cells":1324},"Ciclosporin",{"EARLY_PHASE1":1325,"PHASE1":1327,"PHASE2":1329,"PHASE3":1342,"PHASE4":1344,"NA":1346},{"trials":1326,"activeCount":97},[],{"trials":1328,"activeCount":97},[],{"trials":1330,"activeCount":97},[1331],{"nctId":1332,"briefTitle":1333,"status":143,"phases":1334,"primaryCompletion":1335,"completion":1336,"start":1337,"enrollment":1338,"conditions":1339,"interventions":1341},"NCT02397213","Ciclosporin to Protect Renal Function In Cardiac Surgery",[87],"2016-05","2016-09","2015-04",155,[1340],"Acute Kidney Injury",[1323],{"trials":1343,"activeCount":97},[],{"trials":1345,"activeCount":97},[],{"trials":1347,"activeCount":97},[],{"intervention":1349,"totalTrials":115,"cells":1350},"aerosolized DNase",{"EARLY_PHASE1":1351,"PHASE1":1353,"PHASE2":1355,"PHASE3":1369,"PHASE4":1371,"NA":1373},{"trials":1352,"activeCount":97},[],{"trials":1354,"activeCount":97},[],{"trials":1356,"activeCount":97},[1357],{"nctId":1358,"briefTitle":1359,"status":143,"phases":1360,"primaryCompletion":1361,"completion":1362,"start":1363,"enrollment":1364,"conditions":1365,"interventions":1367},"NCT04541979","Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19",[87],"2022-01-11","2023-01-06","2020-06-04",76,[1366],"COVID-19",[1349,1368],"NaCl",{"trials":1370,"activeCount":97},[],{"trials":1372,"activeCount":97},[],{"trials":1374,"activeCount":97},[],{"intervention":1368,"totalTrials":115,"cells":1376},{"EARLY_PHASE1":1377,"PHASE1":1379,"PHASE2":1381,"PHASE3":1387,"PHASE4":1389,"NA":1391},{"trials":1378,"activeCount":97},[],{"trials":1380,"activeCount":97},[],{"trials":1382,"activeCount":97},[1383],{"nctId":1358,"briefTitle":1359,"status":143,"phases":1384,"primaryCompletion":1361,"completion":1362,"start":1363,"enrollment":1364,"conditions":1385,"interventions":1386},[87],[1366],[1349,1368],{"trials":1388,"activeCount":97},[],{"trials":1390,"activeCount":97},[],{"trials":1392,"activeCount":97},[],{"intervention":1394,"totalTrials":115,"cells":1395},"Clodronate",{"EARLY_PHASE1":1396,"PHASE1":1398,"PHASE2":1400,"PHASE3":1412,"PHASE4":1414,"NA":1416},{"trials":1397,"activeCount":97},[],{"trials":1399,"activeCount":97},[],{"trials":1401,"activeCount":97},[1402],{"nctId":1403,"briefTitle":1404,"status":143,"phases":1405,"primaryCompletion":1406,"completion":1406,"start":1407,"enrollment":1408,"conditions":1409,"interventions":1411},"NCT00658268","Bisphosphonates and Impaction Grafting in Hip Revision",[87],"2017-08-01","2008-03",32,[1410],"Aseptic Loosening of the Hip Prosthesis",[1394],{"trials":1413,"activeCount":97},[],{"trials":1415,"activeCount":97},[],{"trials":1417,"activeCount":97},[],{"intervention":1419,"totalTrials":115,"cells":1420},"Bevacizumab",{"EARLY_PHASE1":1421,"PHASE1":1423,"PHASE2":1425,"PHASE3":1439,"PHASE4":1441,"NA":1443},{"trials":1422,"activeCount":97},[],{"trials":1424,"activeCount":97},[],{"trials":1426,"activeCount":97},[1427],{"nctId":1428,"briefTitle":1429,"status":1267,"phases":1430,"primaryCompletion":1431,"completion":1432,"start":834,"enrollment":1243,"conditions":1433,"interventions":1438},"NCT00804830","Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer",[87],"2012-12","2014-12",[1434,1435,1436,1437],"Thyroid Neoplasms","Carcinoma","Thyroid Cancer","Metastatic Cancer",[1419],{"trials":1440,"activeCount":97},[],{"trials":1442,"activeCount":97},[],{"trials":1444,"activeCount":97},[],{"intervention":1446,"totalTrials":115,"cells":1447},"Erythropoietin zeta",{"EARLY_PHASE1":1448,"PHASE1":1450,"PHASE2":1452,"PHASE3":1466,"PHASE4":1468,"NA":1470},{"trials":1449,"activeCount":97},[],{"trials":1451,"activeCount":97},[],{"trials":1453,"activeCount":97},[1454],{"nctId":1455,"briefTitle":1456,"status":143,"phases":1457,"primaryCompletion":1458,"completion":1459,"start":1460,"enrollment":1461,"conditions":1462,"interventions":1465},"NCT01423955","Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery",[87],"2013-01","2013-04","2011-10",75,[1463,1464],"Kidney Failure","Renal Failure",[1446],{"trials":1467,"activeCount":97},[],{"trials":1469,"activeCount":97},[],{"trials":1471,"activeCount":97},[],{"intervention":1473,"totalTrials":115,"cells":1474},"Angusta™",{"EARLY_PHASE1":1475,"PHASE1":1477,"PHASE2":1490,"PHASE3":1492,"PHASE4":1494,"NA":1496},{"trials":1476,"activeCount":97},[],{"trials":1478,"activeCount":97},[1479],{"nctId":1480,"briefTitle":1481,"status":143,"phases":1482,"primaryCompletion":1483,"completion":579,"start":1484,"enrollment":1485,"conditions":1486,"interventions":1488},"NCT02516631","Comparative Bioavailability Study of Two Misoprostol Formulations",[86],"2015-11","2014-11",72,[1487],"Labour, Induced",[1473,1489,1473,1489,1473,1489],"Cytotec®",{"trials":1491,"activeCount":97},[],{"trials":1493,"activeCount":97},[],{"trials":1495,"activeCount":97},[],{"trials":1497,"activeCount":97},[],{"intervention":1489,"totalTrials":115,"cells":1499},{"EARLY_PHASE1":1500,"PHASE1":1502,"PHASE2":1508,"PHASE3":1510,"PHASE4":1512,"NA":1514},{"trials":1501,"activeCount":97},[],{"trials":1503,"activeCount":97},[1504],{"nctId":1480,"briefTitle":1481,"status":143,"phases":1505,"primaryCompletion":1483,"completion":579,"start":1484,"enrollment":1485,"conditions":1506,"interventions":1507},[86],[1487],[1473,1489,1473,1489,1473,1489],{"trials":1509,"activeCount":97},[],{"trials":1511,"activeCount":97},[],{"trials":1513,"activeCount":97},[],{"trials":1515,"activeCount":97},[],{"intervention":1517,"totalTrials":115,"cells":1518},"Dexamethasone Ophthalmic",{"EARLY_PHASE1":1519,"PHASE1":1521,"PHASE2":1533,"PHASE3":1535,"PHASE4":1537,"NA":1539},{"trials":1520,"activeCount":97},[],{"trials":1522,"activeCount":97},[1523],{"nctId":1524,"briefTitle":1525,"status":143,"phases":1526,"primaryCompletion":1527,"completion":1527,"start":1528,"enrollment":1529,"conditions":1530,"interventions":1532},"NCT05387941","Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants",[86],"2026-03-04","2022-06-14",11,[1531],"Retinopathy of Prematurity",[1517],{"trials":1534,"activeCount":97},[],{"trials":1536,"activeCount":97},[],{"trials":1538,"activeCount":97},[],{"trials":1540,"activeCount":97},[],{"intervention":1542,"totalTrials":115,"cells":1543},"Fentanyl",{"EARLY_PHASE1":1544,"PHASE1":1546,"PHASE2":1548,"PHASE3":1550,"PHASE4":1552,"NA":1554},{"trials":1545,"activeCount":97},[],{"trials":1547,"activeCount":97},[],{"trials":1549,"activeCount":97},[],{"trials":1551,"activeCount":97},[],{"trials":1553,"activeCount":97},[],{"trials":1555,"activeCount":97},[1556],{"nctId":1557,"briefTitle":1558,"status":143,"phases":1559,"primaryCompletion":1560,"completion":1560,"start":1561,"enrollment":1562,"conditions":1563,"interventions":1565},"NCT03177980","Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants",[],"2021-04-01","2017-04-24",49,[1564],"Asphyxia Neonatorum",[1542,1566],"Fentanyl and clonidine",{"intervention":1566,"totalTrials":115,"cells":1568},{"EARLY_PHASE1":1569,"PHASE1":1571,"PHASE2":1573,"PHASE3":1575,"PHASE4":1577,"NA":1579},{"trials":1570,"activeCount":97},[],{"trials":1572,"activeCount":97},[],{"trials":1574,"activeCount":97},[],{"trials":1576,"activeCount":97},[],{"trials":1578,"activeCount":97},[],{"trials":1580,"activeCount":97},[1581],{"nctId":1557,"briefTitle":1558,"status":143,"phases":1582,"primaryCompletion":1560,"completion":1560,"start":1561,"enrollment":1562,"conditions":1583,"interventions":1584},[],[1564],[1542,1566],{"intervention":1586,"totalTrials":115,"cells":1587},"Naloxone Nasal Spray",{"EARLY_PHASE1":1588,"PHASE1":1590,"PHASE2":1592,"PHASE3":1594,"PHASE4":1596,"NA":1598},{"trials":1589,"activeCount":97},[],{"trials":1591,"activeCount":97},[],{"trials":1593,"activeCount":97},[],{"trials":1595,"activeCount":97},[],{"trials":1597,"activeCount":97},[],{"trials":1599,"activeCount":97},[1600],{"nctId":1601,"briefTitle":1602,"status":1238,"phases":1603,"primaryCompletion":1604,"completion":1605,"start":1606,"enrollment":1607,"conditions":1608,"interventions":1610},"NCT03570099","Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications",[],"2020-12-31","2023-07-01","2018-06-11",2000,[1609],"Opioid Abuse",[1586],{"intervention":1612,"totalTrials":115,"cells":1613},"Fish oil",{"EARLY_PHASE1":1614,"PHASE1":1616,"PHASE2":1618,"PHASE3":1620,"PHASE4":1622,"NA":1624},{"trials":1615,"activeCount":97},[],{"trials":1617,"activeCount":97},[],{"trials":1619,"activeCount":97},[],{"trials":1621,"activeCount":97},[],{"trials":1623,"activeCount":97},[],{"trials":1625,"activeCount":97},[1626],{"nctId":1627,"briefTitle":1628,"status":143,"phases":1629,"primaryCompletion":1630,"completion":1630,"start":1631,"enrollment":1632,"conditions":1633,"interventions":1637},"NCT03048981","Effects of Fish Oil on Platelet Function and Coagulation",[90],"2017-05-02","2017-03-01",12,[1634,1635,1636],"Platelet Aggregation, Spontaneous","Atherosclerosis","Surgery",[1612],{"intervention":1639,"totalTrials":115,"cells":1640},"Norepinephrine",{"EARLY_PHASE1":1641,"PHASE1":1643,"PHASE2":1645,"PHASE3":1647,"PHASE4":1649,"NA":1651},{"trials":1642,"activeCount":97},[],{"trials":1644,"activeCount":97},[],{"trials":1646,"activeCount":97},[],{"trials":1648,"activeCount":97},[],{"trials":1650,"activeCount":97},[],{"trials":1652,"activeCount":97},[1653],{"nctId":1654,"briefTitle":1655,"status":143,"phases":1656,"primaryCompletion":1657,"completion":1657,"start":1658,"enrollment":1659,"conditions":1660,"interventions":1663},"NCT06121115","Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit",[],"2024-03-01","2023-10-03",473,[28,1661,1662],"Norepinephrine Adverse Reaction","Hypotension and Shock",[1639],{"intervention":1665,"totalTrials":115,"cells":1666},"Phytomenadione",{"EARLY_PHASE1":1667,"PHASE1":1669,"PHASE2":1671,"PHASE3":1673,"PHASE4":1675,"NA":1677},{"trials":1668,"activeCount":97},[],{"trials":1670,"activeCount":97},[],{"trials":1672,"activeCount":97},[],{"trials":1674,"activeCount":97},[],{"trials":1676,"activeCount":97},[],{"trials":1678,"activeCount":97},[1679],{"nctId":1680,"briefTitle":1681,"status":143,"phases":1682,"primaryCompletion":1683,"completion":1683,"start":1684,"enrollment":1685,"conditions":1686,"interventions":1690},"NCT03782025","Effect of Vitamin K in Critically Ill Patients",[],"2020-03-20","2019-02-13",52,[1687,1688,1689],"Coagulation Factor Deficiency","Coagulopathy, Consumption","Vitamin K Deficiency",[1665],{"intervention":1692,"totalTrials":115,"cells":1693},"0,5 mg Prevenar i.m.",{"EARLY_PHASE1":1694,"PHASE1":1696,"PHASE2":1698,"PHASE3":1700,"PHASE4":1702,"NA":1704},{"trials":1695,"activeCount":97},[],{"trials":1697,"activeCount":97},[],{"trials":1699,"activeCount":97},[],{"trials":1701,"activeCount":97},[],{"trials":1703,"activeCount":97},[],{"trials":1705,"activeCount":97},[1706],{"nctId":1707,"briefTitle":1708,"status":143,"phases":1709,"primaryCompletion":1710,"completion":1711,"start":1460,"enrollment":908,"conditions":1712,"interventions":1717},"NCT02240888","Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response",[90],"2017-12-31","2018-05-31",[1713,169,1714,165,1715,1716],"RA","Vasculitis","Sjögrens","Syndrome",[1692,1718],"0,5 mg seasonal influenza vaccine i.m.",{"intervention":1718,"totalTrials":115,"cells":1720},{"EARLY_PHASE1":1721,"PHASE1":1723,"PHASE2":1725,"PHASE3":1727,"PHASE4":1729,"NA":1731},{"trials":1722,"activeCount":97},[],{"trials":1724,"activeCount":97},[],{"trials":1726,"activeCount":97},[],{"trials":1728,"activeCount":97},[],{"trials":1730,"activeCount":97},[],{"trials":1732,"activeCount":97},[1733],{"nctId":1707,"briefTitle":1708,"status":143,"phases":1734,"primaryCompletion":1710,"completion":1711,"start":1460,"enrollment":908,"conditions":1735,"interventions":1736},[90],[1713,169,1714,165,1715,1716],[1692,1718],{"intervention":1738,"totalTrials":115,"cells":1739},"E. coli 83972",{"EARLY_PHASE1":1740,"PHASE1":1742,"PHASE2":1744,"PHASE3":1746,"PHASE4":1748,"NA":1750},{"trials":1741,"activeCount":97},[],{"trials":1743,"activeCount":97},[],{"trials":1745,"activeCount":97},[],{"trials":1747,"activeCount":97},[],{"trials":1749,"activeCount":97},[],{"trials":1751,"activeCount":97},[1752],{"nctId":1753,"briefTitle":1754,"status":143,"phases":1755,"primaryCompletion":1756,"completion":1756,"start":1757,"enrollment":425,"conditions":1758,"interventions":1760},"NCT00927316","E. Coli 83972 Induced Asymptomatic Bacteriuria (ABU) in Patients With Recurrent Urinary Tract Infections (UTI)",[90],"2006-12","2003-03",[1759],"Urinary Tract Infection",[1738],{"intervention":1762,"totalTrials":115,"cells":1763},"Platelet transfusion",{"EARLY_PHASE1":1764,"PHASE1":1766,"PHASE2":1768,"PHASE3":1770,"PHASE4":1772,"NA":1774},{"trials":1765,"activeCount":97},[],{"trials":1767,"activeCount":97},[],{"trials":1769,"activeCount":97},[],{"trials":1771,"activeCount":97},[],{"trials":1773,"activeCount":97},[],{"trials":1775,"activeCount":97},[1776],{"nctId":1777,"briefTitle":1778,"status":143,"phases":1779,"primaryCompletion":1336,"completion":1336,"start":579,"enrollment":1780,"conditions":1781,"interventions":1784},"NCT02601131","Post-transfusion Platelet Count",[],80,[1782,1783],"Leukemia","Multiple Sclerosis",[1762],{"intervention":1786,"totalTrials":115,"cells":1787},"GA-arm, remifentanil",{"EARLY_PHASE1":1788,"PHASE1":1790,"PHASE2":1792,"PHASE3":1794,"PHASE4":1796,"NA":1798},{"trials":1789,"activeCount":97},[],{"trials":1791,"activeCount":97},[],{"trials":1793,"activeCount":97},[],{"trials":1795,"activeCount":97},[],{"trials":1797,"activeCount":97},[],{"trials":1799,"activeCount":97},[1800],{"nctId":1801,"briefTitle":1802,"status":143,"phases":1803,"primaryCompletion":1804,"completion":1805,"start":1458,"enrollment":1806,"conditions":1807,"interventions":1808},"NCT01733472","General or Regional Anesthesia for Hip Surgery",[90],"2014-02","2014-06",120,[18],[1786,1809],"RA-arm",{"intervention":1809,"totalTrials":115,"cells":1811},{"EARLY_PHASE1":1812,"PHASE1":1814,"PHASE2":1816,"PHASE3":1818,"PHASE4":1820,"NA":1822},{"trials":1813,"activeCount":97},[],{"trials":1815,"activeCount":97},[],{"trials":1817,"activeCount":97},[],{"trials":1819,"activeCount":97},[],{"trials":1821,"activeCount":97},[],{"trials":1823,"activeCount":97},[1824],{"nctId":1801,"briefTitle":1802,"status":143,"phases":1825,"primaryCompletion":1804,"completion":1805,"start":1458,"enrollment":1806,"conditions":1826,"interventions":1827},[90],[18],[1786,1809],{"intervention":1829,"totalTrials":115,"cells":1830},"dexmedetomidine",{"EARLY_PHASE1":1831,"PHASE1":1833,"PHASE2":1835,"PHASE3":1837,"PHASE4":1839,"NA":1841},{"trials":1832,"activeCount":97},[],{"trials":1834,"activeCount":97},[],{"trials":1836,"activeCount":97},[],{"trials":1838,"activeCount":97},[],{"trials":1840,"activeCount":97},[],{"trials":1842,"activeCount":97},[1843],{"nctId":1844,"briefTitle":1845,"status":1125,"phases":1846,"primaryCompletion":1847,"completion":1848,"start":1849,"enrollment":97,"conditions":1850,"interventions":1854},"NCT06482775","Dexmedetomidine for Analgosedation to Newborn Infants During Neonatal Intensive Care",[],"2021-12-01","2021-12-31","2021-06-01",[1851,1852,1853],"Intensive Care, Neonatal","Analgesia","Hypnotics and Sedatives",[1829],{"intervention":1856,"totalTrials":115,"cells":1857},"misoprostol",{"EARLY_PHASE1":1858,"PHASE1":1860,"PHASE2":1862,"PHASE3":1864,"PHASE4":1866,"NA":1868},{"trials":1859,"activeCount":97},[],{"trials":1861,"activeCount":97},[],{"trials":1863,"activeCount":97},[],{"trials":1865,"activeCount":97},[],{"trials":1867,"activeCount":97},[],{"trials":1869,"activeCount":97},[1870],{"nctId":1871,"briefTitle":1872,"status":143,"phases":1873,"primaryCompletion":1874,"completion":1875,"start":1876,"enrollment":1877,"conditions":1878,"interventions":1880},"NCT01033903","Optimal Treatment of Miscarriage",[90],"2015-12","2018-03-01","2008-10-01",190,[1879],"Abortion, Spontaneous",[1856],{"intervention":1882,"totalTrials":115,"cells":1883},"Dexamethasone eyedrop",{"EARLY_PHASE1":1884,"PHASE1":1886,"PHASE2":1888,"PHASE3":1890,"PHASE4":1892,"NA":1894},{"trials":1885,"activeCount":97},[],{"trials":1887,"activeCount":97},[],{"trials":1889,"activeCount":97},[],{"trials":1891,"activeCount":97},[],{"trials":1893,"activeCount":97},[],{"trials":1895,"activeCount":97},[1896],{"nctId":1897,"briefTitle":1898,"status":143,"phases":1899,"primaryCompletion":1900,"completion":1901,"start":1902,"enrollment":1903,"conditions":1904,"interventions":1906},"NCT06775353","To Assess the Effect of Dexamethasone Eye Drops on the Retinopathy of Prematurity Outcome",[],"2024-12-31","2025-01-01","2022-12-01",2017,[1905],"Retinopathy of Prematurity (ROP)",[1882],{"intervention":1908,"totalTrials":115,"cells":1909},"Clonidine",{"EARLY_PHASE1":1910,"PHASE1":1912,"PHASE2":1914,"PHASE3":1916,"PHASE4":1918,"NA":1920},{"trials":1911,"activeCount":97},[],{"trials":1913,"activeCount":97},[],{"trials":1915,"activeCount":97},[],{"trials":1917,"activeCount":97},[],{"trials":1919,"activeCount":97},[],{"trials":1921,"activeCount":97},[1922],{"nctId":1923,"briefTitle":1924,"status":143,"phases":1925,"primaryCompletion":1926,"completion":1926,"start":1927,"enrollment":470,"conditions":1928,"interventions":1929},"NCT04928651","Clonidine for Analgesia to Preterm Infants During Neonatal Intensive Care",[],"2022-05-13","2018-04-06",[1851,1852,1853],[1908],{"intervention":1931,"totalTrials":115,"cells":1932},"Mupirocin",{"EARLY_PHASE1":1933,"PHASE1":1935,"PHASE2":1937,"PHASE3":1939,"PHASE4":1941,"NA":1943},{"trials":1934,"activeCount":97},[],{"trials":1936,"activeCount":97},[],{"trials":1938,"activeCount":97},[],{"trials":1940,"activeCount":97},[],{"trials":1942,"activeCount":97},[],{"trials":1944,"activeCount":97},[1945],{"nctId":1946,"briefTitle":1947,"status":143,"phases":1948,"primaryCompletion":1949,"completion":1949,"start":1950,"enrollment":1951,"conditions":1952,"interventions":1954},"NCT01269541","MESS-study MRSA Eradication Study Skåne",[90],"2015-05-01","2011-03-01",69,[1953],"Throatcarriers of MRSA",[1931,1955],"Rifampin+Clindamycine or Trimehoprimsulfa",{"intervention":1955,"totalTrials":115,"cells":1957},{"EARLY_PHASE1":1958,"PHASE1":1960,"PHASE2":1962,"PHASE3":1964,"PHASE4":1966,"NA":1968},{"trials":1959,"activeCount":97},[],{"trials":1961,"activeCount":97},[],{"trials":1963,"activeCount":97},[],{"trials":1965,"activeCount":97},[],{"trials":1967,"activeCount":97},[],{"trials":1969,"activeCount":97},[1970],{"nctId":1946,"briefTitle":1947,"status":143,"phases":1971,"primaryCompletion":1949,"completion":1949,"start":1950,"enrollment":1951,"conditions":1972,"interventions":1973},[90],[1953],[1931,1955],{"intervention":1975,"totalTrials":115,"cells":1976},"MTX start",{"EARLY_PHASE1":1977,"PHASE1":1979,"PHASE2":1981,"PHASE3":1983,"PHASE4":1985,"NA":1987},{"trials":1978,"activeCount":97},[],{"trials":1980,"activeCount":97},[],{"trials":1982,"activeCount":97},[],{"trials":1984,"activeCount":97},[],{"trials":1986,"activeCount":97},[],{"trials":1988,"activeCount":97},[1989],{"nctId":1990,"briefTitle":1991,"status":143,"phases":1992,"primaryCompletion":1993,"completion":1994,"start":1995,"enrollment":518,"conditions":1996,"interventions":1997},"NCT03775824","Faecal Analyses in Rheumatoid Arthritis Therapy",[],"2018-11-01","2019-06-01","2016-08-01",[149],[1975,1998],"TNF start",{"intervention":1998,"totalTrials":115,"cells":2000},{"EARLY_PHASE1":2001,"PHASE1":2003,"PHASE2":2005,"PHASE3":2007,"PHASE4":2009,"NA":2011},{"trials":2002,"activeCount":97},[],{"trials":2004,"activeCount":97},[],{"trials":2006,"activeCount":97},[],{"trials":2008,"activeCount":97},[],{"trials":2010,"activeCount":97},[],{"trials":2012,"activeCount":97},[2013],{"nctId":1990,"briefTitle":1991,"status":143,"phases":2014,"primaryCompletion":1993,"completion":1994,"start":1995,"enrollment":518,"conditions":2015,"interventions":2016},[],[149],[1975,1998],{"intervention":2018,"totalTrials":115,"cells":2019},"mycophenolic acid",{"EARLY_PHASE1":2020,"PHASE1":2022,"PHASE2":2024,"PHASE3":2026,"PHASE4":2028,"NA":2030},{"trials":2021,"activeCount":97},[],{"trials":2023,"activeCount":97},[],{"trials":2025,"activeCount":97},[],{"trials":2027,"activeCount":97},[],{"trials":2029,"activeCount":97},[],{"trials":2031,"activeCount":97},[2032],{"nctId":2033,"briefTitle":2034,"status":143,"phases":2035,"primaryCompletion":2036,"completion":2037,"start":2038,"enrollment":2039,"conditions":2040,"interventions":2043},"NCT03678987","Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis",[],"2020-01-01","2020-02-01","2018-09-13",35,[2041,2042],"Systemic Sclerosis","Gastrointestinal Complication",[2018],{"intervention":2045,"totalTrials":115,"cells":2046},"Mepolizumab",{"EARLY_PHASE1":2047,"PHASE1":2049,"PHASE2":2051,"PHASE3":2053,"PHASE4":2055,"NA":2057},{"trials":2048,"activeCount":97},[],{"trials":2050,"activeCount":97},[],{"trials":2052,"activeCount":97},[],{"trials":2054,"activeCount":97},[],{"trials":2056,"activeCount":97},[],{"trials":2058,"activeCount":97},[2059],{"nctId":2060,"briefTitle":2061,"status":1238,"phases":2062,"primaryCompletion":2063,"completion":2064,"start":1004,"enrollment":1780,"conditions":2065,"interventions":2066},"NCT05689931","Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting",[],"2024-04-01","2024-12-18",[348],[2045,2067],"Standard inhaled corticosteroids",{"intervention":2067,"totalTrials":115,"cells":2069},{"EARLY_PHASE1":2070,"PHASE1":2072,"PHASE2":2074,"PHASE3":2076,"PHASE4":2078,"NA":2080},{"trials":2071,"activeCount":97},[],{"trials":2073,"activeCount":97},[],{"trials":2075,"activeCount":97},[],{"trials":2077,"activeCount":97},[],{"trials":2079,"activeCount":97},[],{"trials":2081,"activeCount":97},[2082],{"nctId":2060,"briefTitle":2061,"status":1238,"phases":2083,"primaryCompletion":2063,"completion":2064,"start":1004,"enrollment":1780,"conditions":2084,"interventions":2085},[],[348],[2045,2067],{"intervention":2087,"totalTrials":115,"cells":2088},"Opioid maintenance treatment",{"EARLY_PHASE1":2089,"PHASE1":2091,"PHASE2":2093,"PHASE3":2095,"PHASE4":2097,"NA":2099},{"trials":2090,"activeCount":97},[],{"trials":2092,"activeCount":97},[],{"trials":2094,"activeCount":97},[],{"trials":2096,"activeCount":97},[],{"trials":2098,"activeCount":97},[],{"trials":2100,"activeCount":97},[2101],{"nctId":2102,"briefTitle":2103,"status":1238,"phases":2104,"primaryCompletion":2105,"completion":2106,"start":2107,"enrollment":2108,"conditions":2109,"interventions":2112},"NCT05678036","Effects on Mortality and Clinical Course of a Patient's Choice Model for Opioid Maintenance Treatment for Opioid Dependence - Evaluation of a System Enabling a Large Expansion of Treatment Providers and Treatment Access",[],"2023-09-30","2024-07-31","2023-01-31",2500,[2110,2111],"Opioid Dependence","Overdose",[2087],{"intervention":2114,"totalTrials":115,"cells":2115},"Mepivacaine, Combinations",{"EARLY_PHASE1":2116,"PHASE1":2118,"PHASE2":2120,"PHASE3":2122,"PHASE4":2124,"NA":2126},{"trials":2117,"activeCount":97},[],{"trials":2119,"activeCount":97},[],{"trials":2121,"activeCount":97},[],{"trials":2123,"activeCount":97},[],{"trials":2125,"activeCount":97},[],{"trials":2127,"activeCount":97},[2128],{"nctId":2129,"briefTitle":2130,"status":1238,"phases":2131,"primaryCompletion":1900,"completion":53,"start":2132,"enrollment":1806,"conditions":2133,"interventions":2134},"NCT06172400","Wide Awake Open Carpal Tunnel Release With or Without a Tourniquet",[90],"2024-01-09",[568],[2114],{"intervention":2136,"totalTrials":115,"cells":2137},"General Anesthesia",{"EARLY_PHASE1":2138,"PHASE1":2140,"PHASE2":2142,"PHASE3":2144,"PHASE4":2146,"NA":2148},{"trials":2139,"activeCount":97},[],{"trials":2141,"activeCount":97},[],{"trials":2143,"activeCount":97},[],{"trials":2145,"activeCount":97},[],{"trials":2147,"activeCount":97},[],{"trials":2149,"activeCount":97},[2150],{"nctId":2151,"briefTitle":2152,"status":143,"phases":2153,"primaryCompletion":2154,"completion":2155,"start":2156,"enrollment":280,"conditions":2157,"interventions":2158},"NCT01604382","Early Mobilization After Total Knee Arthroplasty",[90],"2009-05","2010-06","2008-09",[18],[2136,2159],"Neuraxial anesthesia",{"intervention":2159,"totalTrials":115,"cells":2161},{"EARLY_PHASE1":2162,"PHASE1":2164,"PHASE2":2166,"PHASE3":2168,"PHASE4":2170,"NA":2172},{"trials":2163,"activeCount":97},[],{"trials":2165,"activeCount":97},[],{"trials":2167,"activeCount":97},[],{"trials":2169,"activeCount":97},[],{"trials":2171,"activeCount":97},[],{"trials":2173,"activeCount":97},[2174],{"nctId":2151,"briefTitle":2152,"status":143,"phases":2175,"primaryCompletion":2154,"completion":2155,"start":2156,"enrollment":280,"conditions":2176,"interventions":2177},[90],[18],[2136,2159]]